TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Karo Pharma Norge AS
Closing information (x1000 NOK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 0 | 0 | 210 |
Financial expenses | 14,516 | 14,282 | 14,494 |
Earnings before taxes | 51,263 | 103,893 | 11,917 |
Total assets | 1,452,494 | 1,487,226 | 1,404,079 |
Current assets | 78,942 | 102,273 | 65,569 |
Current liabilities | 53,535 | 79,059 | 7,259 |
Equity capital | 1,163,513 | 1,123,442 | 1,050,320 |
- share capital | 273,541 | 338,599 | 265,477 |
Employees (average) | 0 | 0 | 0 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 80.1% | 75.5% | 74.8% |
Turnover per employee | |||
Profit as a percentage of turnover | 5674.8% | ||
Return on assets (ROA) | 4.5% | 7.9% | 1.9% |
Current ratio | 147.5% | 129.4% | 903.3% |
Return on equity (ROE) | 4.4% | 9.2% | 1.1% |
Change turnover | 0 | -210 | -399,528 |
Change turnover % | -100% | ||
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.